# CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)

> **NCT00973505** · — · UNKNOWN · sponsor: **Korea University Anam Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Breast Neoplasms
- Arthralgia
- Arthritis
- Genetic Polymorphism

## Interventions

- **DRUG:** Aromatase Inhibitor(Femara or Arimidex)

## Key facts

- **NCT ID:** NCT00973505
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973505, "CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00973505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*